Magne Rekdal

ORCID: 0000-0002-7213-8071
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Disease Management Strategies
  • Esophageal and GI Pathology
  • Diabetes Management and Research
  • Bariatric Surgery and Outcomes
  • Gastroesophageal reflux and treatments
  • Folate and B Vitamins Research
  • Diabetes and associated disorders
  • Diabetes Management and Education
  • Neurological and metabolic disorders
  • Health Promotion and Cardiovascular Prevention
  • Diabetes Treatment and Management
  • Obesity and Health Practices
  • Neurofibromatosis and Schwannoma Cases
  • Vascular Malformations Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Health Systems, Economic Evaluations, Quality of Life
  • Alcoholism and Thiamine Deficiency

Clinical Trial Investigators
2023

Norwegian Academy of Science and Letters
2019-2023

Haukeland University Hospital
2023

Weatherford College
2023

Oslo University Hospital
2023

University of Bergen
2023

NORCE Norwegian Research Centre
2007

Importance Current guidelines for treating small- to medium-sized vestibular schwannoma recommend either upfront radiosurgery or waiting treat until tumor growth has been detected radiographically. Objective To determine whether provides superior volume reduction a wait-and-scan approach schwannoma. Design, Setting, and Participants Randomized clinical trial of 100 patients with newly diagnosed (<6 months) unilateral maximal diameter less than 2 cm in the cerebellopontine angle as...

10.1001/jama.2023.12222 article EN JAMA 2023-08-01

Objective To pilot test the proposed DiaPROM trial components and address uncertainties associated with conducting a full-scale randomised controlled (RCT) to evaluate whether such is feasible. Design Two-arm RCT. Participants Adults aged ≥18–39 years, minimum 1 year type diabetes duration, attending outpatient follow-up. Exclusion criteria were pregnancy, severe cognitive, somatic or psychiatric conditions impaired vision. Randomisation intervention All participants completed electronic...

10.1136/bmjopen-2020-042353 article EN cc-by-nc BMJ Open 2021-04-01

Objective. To assess level of cardiovascular risk factors in a non-selected, middle-aged population. estimate the proportion target for intervention according to present guidelines and different cut-off levels two algorithms. Design. Population survey, modelling study. Setting. The Norwegian Hordaland Health Study (HUSK) 1997–99. Subjects. A total 22 289 persons born 1950–57. Main outcome measures. Own relatives’ morbidity, antihypertensive lipid-lowering treatment, smoking, blood pressure,...

10.1080/02813430701241087 article EN Scandinavian Journal of Primary Health Care 2007-01-01

Background Patients with type 1 diabetes mellitus (T1DM) and poor glycaemic control are at high risk of developing microvascular macrovascular complications. The aim this study was to determine if a quality improvement collaborative (QIC) initiated by the Norwegian Diabetes Register for adults (NDR-A) could reduce proportion patients T1DM (defined as glycated haemoglobin (HbA1c)≥75 mmol/mol) mean HbA1c participating clinics compared 14 clinics. Method Multicentre controlled before after...

10.1136/bmjoq-2022-002099 article EN cc-by-nc BMJ Open Quality 2023-06-01

We investigated whether adding gastropexy to sleeve gastrectomy (SG) reduced gastroesophageal reflux disease (GERD) in patients operated for severe obesity, assessed mainly by use of anti-reflux medication (ARM) and second operations due GERD worsening. In a prospective non-randomized study, undergoing SG at two Norwegian hospitals were included from 2011 2015 followed 7 years. was defined regular ARM, epigastric pain heartburn measured the Rome II questionnaire. Gastropexy done suturing...

10.1111/cob.12618 article EN cc-by Clinical Obesity 2023-08-15

Abstract Background/Objectives Gastopexy (G) has been introduced as a surgical technique to reduce gastroesophageal reflux disease (GERD) in patients undergoing sleeve gastrectomy (SG). We aimed determine whether adding G SG improves use of acid reducing medication (ARM), second operations for GERD, epigastric pain or heartburn after surgery. Subjects/Methods Patients at two Norwegian hospitals were included consecutively from 2011 2015. Data was collected prospectively up 7 years GERD...

10.21203/rs.3.rs-2419066/v1 preprint EN cc-by Research Square (Research Square) 2023-01-05

Background: The NDR-A is a national diabetes quality register. Norwegian health authorities specify that registers must include data from Patient-Reported Outcome Measures (PROMs) in addition to biomedical data. retrieves electronic patient records (EPR). This raises the possibility of utilizing PROMs clinical consultations. main PROM included Problem Areas Diabetes scale (PAID). Aim: To test feasibility using delivery mode collect and examine how patients care providers experience EPR’s...

10.2337/db20-2233-pub article EN Diabetes 2020-06-01
Coming Soon ...